For example, patients with macular degeneration, a complement-mediated disease, were found to have a much higher risk of developing severe COVID-19, suggesting a possible connection between the increased presence of complement proteins and worse COVID-19 outcome [20]. This evidence concerns the gene VTN and COVID-19.